A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

More than 35,000 cases of the mosquito-borne disease have been reported on the French Indian Ocean island since August 2024.

The highest risk of transmission of SARS-CoV-2 was in the first 72 hours at room temperature and first 24 hours at 37℃.

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

PHILADELPHIA, PA — The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s ...

Some assume pneumonia is an inevitable consequence of ageing, while others may not realise they are at risk, says infectious ...

"The mpox virus is primarily spread by prolonged close contact, typically skin-to-skin, often during sexual activity.

Vermont has the second lowest state fatality rate in the US (146.9 per 100K; Hawaii 112.8/100K). Mississippi (464.2/100K) and ...

Experts are warning about the dangers of the flu as childhood jab rates across NSW fall, urging parents to vaccinate their ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

OAZisCare, digitally powered by DocquityCare, has advanced patient education and adherence for cancer care and RSV vaccines since 2024 The collaboration helps tackle Southeast Asia's healthcare needs, ...

A panel of federal health experts recommended expanded vaccine options for several diseases, including RSV, meningitis, and chikungunya.